37 results
424B3
BIAF
BioAffinity Technologies Inc
22 May 24
Prospectus supplement
4:00pm
Operating leases:
Operating lease right-of-use assets
Operating lease liability, current
Operating lease liability, long-term
Finance leases:
Finance lease … liability, long-term
Total finance lease liabilities
Weighted-average remaining lease term:
Operating leases (in years)
Finance leases (in years
424B3
BIAF
BioAffinity Technologies Inc
22 May 24
Prospectus supplement
4:00pm
lease right-of-use assets
Operating lease liability, current
Operating lease liability, long-term
Finance leases:
Finance lease right-of-use asset … , gross
Accumulated amortization
Finance lease right-of-use asset, net
Finance lease liability, current portion
Finance lease liability, long-term
Total
424B3
BIAF
BioAffinity Technologies Inc
16 Apr 24
Prospectus supplement
7:19pm
for clinical or commercial production. In addition, we are not a party to any long-term agreement with any of our suppliers such as the reagents used … near- and long-term effects on the biotechnology industry and its participants, such as our vendors, suppliers, and investors, may also adversely
POS AM
bmsbo3mnlo1 sj9e0
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
424B5
f3pyuyetyqshdt0
8 Mar 24
Prospectus supplement for primary offering
12:18pm
424B5
vqe2aba4 92c53kntxr
7 Mar 24
Prospectus supplement for primary offering
9:57pm
424B5
59r1o5qwk1m9yz7
28 Nov 23
Prospectus supplement for primary offering
4:00pm
S-3
unb96
16 Nov 23
Shelf registration
5:23pm
8-K
EX-99.2
s42d6kf 74
20 Sep 23
Entry into a Material Definitive Agreement
4:52pm
8-K
EX-99.3
u6gdnbv071ru j0
20 Sep 23
Entry into a Material Definitive Agreement
4:52pm
8-K
EX-10.2
w8zqz4bfs9 r4
20 Sep 23
Entry into a Material Definitive Agreement
4:52pm
8-K
EX-10.6
o6blzl0g1nr6gd jd0l7
20 Sep 23
Entry into a Material Definitive Agreement
4:52pm